SCHEMBL20236173

SCHEMBL20236173

O=C(O)c1ccc(CNc2ccc(F)cc2F)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.54
ALDH1A1 P00352 1/20 0.54
HPGD P15428 1/20 0.54
HSD17B10 Q99714 1/20 0.54
CTDSP1 Q9GZU7 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
GAA P10253 2/20 0.53
RAB9A P51151 2/20 0.53
NPC1 O15118 1/20 0.53
NFKB1 P19838 1/20 0.53
NFKB2 Q00653 1/20 0.53
RELA Q04206 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
SHMT2 P34897 1/20 0.52
PPARA Q07869 3/20 0.51
VNN1 O95497 2/20 0.50
HDAC4 P56524 1/20 0.49
MEF2D Q14814 1/20 0.49
PYGL P06737 1/20 0.48
HDAC1 Q13547 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15761751 0.84 SMN1; SMN2 (0.60) GAARAB9ANPC1SMN1; SMN2SHMT2
SCHEMBL29878904 0.84 SMN1; SMN2 (0.60) GAARAB9ANPC1SMN1; SMN2SHMT2
SCHEMBL14376791 0.84 L3MBTL1 (0.50) POLBALDH1A1HPGDHSD17B10CTDSP1
SCHEMBL1711030 0.83 HDAC8 (0.59) POLBALDH1A1HPGDHSD17B10CTDSP1
SCHEMBL20401097 0.82 PTGFR (0.53) POLBALDH1A1HPGDHSD17B10CTDSP1
SCHEMBL693716 0.81 ALDH1A1 (0.69) POLBALDH1A1HPGDHSD17B10CTDSP1
SCHEMBL5203429 0.80 SHMT2 (0.56) POLBALDH1A1HSD17B10L3MBTL1GAA
SCHEMBL6840327 0.80 ALDH1A1 (0.55) POLBALDH1A1HPGDHSD17B10CTDSP1
SCHEMBL1663181 0.78 PPARA (0.64) POLBALDH1A1HPGDHSD17B10CTDSP1
SCHEMBL11935975 0.78 SHMT2 (0.57) POLBALDH1A1GAASMN1; SMN2SHMT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3331864-A2 1,3,4-OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Chong Kun Dang Pharmaceutical Corp. (KR) 2018-06-13 EP disclosed